The effects of serial locoregional water-filtered infrared A radiation on wound healing in thoracotomized patients - a randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00021264

Enrollment

Registered

2020-04-07

Start date

2020-05-04

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

All thoracotomized patients undergoing elective open heart surgery (valve and/or bypass surgery) and are postoperatively treated in the cardiosurgical intensive care unit of the Kerckhoff-Klinik Bad Nauheim. Z98

Interventions

Group 1: Physiotherapeutic standard therapy after thoracotomy + additive serial locoregional water-filtered infrared A radiation (asl-wIRAS) Group 2: Physiotherapeutic standard therapy after thoracoto

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All thoracotomized patients undergoing elective open heart surgery (valve and/or bypass surgery) and are postoperatively treated in the cardiosurgical intensive care unit of the Kerckhoff-Klinik Bad Nauheim.

Exclusion criteria

Exclusion criteria: No written consent and approval for the study

Design outcomes

Primary

Measure	Time frame
Reduction of pain measured on a numerical ranking scale (0 - 10) after x days of treatment	—

Secondary

Measure	Time frame
Secondary outcome parameters (descriptive): sPO2, pain medication requirement (analgesic quantity - maximum daily quantity), wound healing, pro- and anti-inflammatory cytokines (including TNF-alpha, interleukin 1, -6, -10), inflammation parameters (BSG, CRP), secretolysis, wound healing In addition, sociodemographic data such as age, gender, height, weight, BMI, previous illnesses, time spent in intensive care. Statistical analysis is carried out by the statistics office Mogk und Reitze in Gießen.	—

Measure

Time frame

Secondary outcome parameters (descriptive): sPO2, pain medication requirement (analgesic quantity - maximum daily quantity), wound healing, pro- and anti-inflammatory cytokines (including TNF-alpha, interleukin 1, -6, -10), inflammation parameters (BSG, CRP), secretolysis, wound healing In addition, sociodemographic data such as age, gender, height, weight, BMI, previous illnesses, time spent in intensive care. Statistical analysis is carried out by the statistics office Mogk und Reitze in Gießen.

—

Countries

Germany

Contacts

Public ContactPhilipp Klemm

Campus Kerckhoff der Justus Liebig Universität Giessen, Abt. für Rheumatologie, Immunologie, Osteologie und Physikalische Medizin

p.klemm@kerckhoff-klinik.de06032-996-2101

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026